MARKET

OKUR

OKUR

OnKure Therapeutics
NASDAQ
5.00
0.00
0.00%
Closed 16:00 03/20 EDT
OPEN
5.06
PREV CLOSE
5.00
HIGH
5.11
LOW
4.850
VOLUME
6.32K
TURNOVER
--
52 WEEK HIGH
20.00
52 WEEK LOW
4.450
MARKET CAP
67.18M
P/E (TTM)
-0.3272
1D
5D
1M
3M
1Y
5Y
1D
OnKure Therapeutics Price Target Cut to $34.00/Share From $40.00 by HC Wainwright & Co.
Dow Jones · 2d ago
OnKure Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 2d ago
HC Wainwright & Co. Maintains Buy on OnKure Therapeutics, Lowers Price Target to $34
Benzinga · 2d ago
ONKURE THERAPEUTICS, INC. <OKUR.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $34 FROM $40
Reuters · 2d ago
U.S. RESEARCH ROUNDUP-American Electric Power, Block, Lenz Therapeutics
Reuters · 2d ago
Weekly Report: what happened at OKUR last week (0310-0314)?
Weekly Report · 3d ago
Gilead Sciences To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga · 03/11 13:12
OnKure Therapeutics Is Maintained at Outperform by Oppenheimer
Dow Jones · 03/11 12:50
More
About OKUR
OnKure Therapeutics, Inc., formerly Reneo Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company focused on the discovery and development of precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. Using a structure-based drug design platform, the Company is building a robust pipeline of tumor-agnostic candidates. The Company is developing OKI-219, a selective PI3KαH1047R inhibitor, as its lead program. OKI-219 is being evaluated in a Phase I clinical trial in solid tumor patients with PI3KαH1047R mutations, including breast cancer. The Company is also focused on targeting oncogenic PI3Kα and has multiple programs designed to enable targeting of this key oncogene.

Webull offers Onkure Therapeutics Inc stock information, including NASDAQ: OKUR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OKUR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OKUR stock methods without spending real money on the virtual paper trading platform.